is hims still selling semaglutide & Hers falls 8% as FDA issues warning letter over compounded weight loss drug FDA Blocks Hims & Hers

While certain side effects of semaglutide have been characterized as concerning by researchers, GLP-1s are not uniquely dangerous

Ongoing support includes monthly check-ins with your provider to assess tolerance, monitor side effects, and adjust your dose as needed

But the question I have is when you were giving this to the diabetics, which was the precedent, that was really what these drugs were first intended, they didn't lose that much weight, and they never, still today when it's looked at for obese non-diabetics versus diabetics, there's a gap in weight loss

Consult a healthcare provider before use, as compounded semaglutide may interact with other drugs or worsen existing health conditions

A maintenance plan might involve ongoing injections of 50-100 mg weekly or as directed by the prescribing provider